In silico, in vitro and cellular analysis with a kinome-wide inhibitor panel correlates cellular LRRK2 dephosphorylation to inhibitor activity on LRRK2
Leucine-rich repeat kinase 2 (LRRK2) is a complex, multidomain protein which is considered a valuable target for potential disease-modifying therapeutic strategies for Parkinson's disease (PD). In mammalian cells and brain, LRRK2 is phosphorylated and treatment of cells with inhibitors of LRRK2...
Main Authors: | , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Frontiers Media S.A.
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4042160/ |